Received Jun 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | Y005808 | — |
Nurse confirmed their facility has not received any reports of the patient involved experiencing any medical concerns or side effects after being administered the improperly stored dose of MMR II.; Nurse calling with a report of an adverse event regarding an improperly stored and administered dose of MMR II. Nurse stated that the MMR II was involved in a temperature excursion on 3/4/2025 and administered to a patient on 3/31/2025; This spontaneous report was received from Nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 04-Mar-2025, Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (lot #Y005808, expiration date: 12-Mar-2026) was involved in a temperature excursion and on 31-Mar-2025, the patient received 0.5 mL, of a two dose series of the improperly storage Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (strength and route of administration not provided) diluted with therapy with sterile diluent (MERCK STERILE DILUENT), 0.5 mL (indication, expiration date, and lot # were not reported) for prophylaxis. Nurse confirmed their facility had not received any reports of the patient involved experiencing any medical concerns or side effects after being administered the improperly stored dose of vaccine.
Sterile diluent